PEB - Pacific Edge Ltd

[clip]

Nuclear war = fallout = exponential cancer = PEB shares @ $27.50

Here's hoping for nuclear war! 5 words I never thought i'd say

[Minerbarejet]

Nuclear war = fallout = exponential cancer = PEB shares @ $27.50

= reduced population=no sharemarket=PEB shares@ 0.00.

[Whipmoney]

CertNdx lost CMS coverage because of Obamacare and tougher regulation. In the long run that's a very good thing for PEB because bogus products won't be funded and can't compete.

Was it really due to the Affordable Care Act though or was poor science to blame?

[Bobcat.]

=emp=no internet=no ST=less ramping=$1.50

[Casino]

Was it really due to the Affordable Care Act though or was poor science to blame?

both - before healthcare reforms it was easy to make money with diagnostic tools of questionable value. must read for PEB holders:

http://media.drugwonks.com/media/att...pdf?1374059870

[skid]

Here's hoping for nuclear war! 5 words I never thought i'd say

5 words I never thought anyone would say-

Once in a while i read a post (even on here) and my jaw just hits the table

[Whipmoney]

both - before healthcare reforms it was easy to make money with diagnostic tools of questionable value. must read for PEB holders:

http://media.drugwonks.com/media/att...pdf?1374059870

Interesting article. We hear a lot on this forum about CMS coverage but has anyone considered the impact of PEB not receiving this? Surely this would send the share price into a tailspin as its their largest viable market..?

Do you think they would go back to the drawing board/lab? Or fold like Predictive Bioscience?

[MAC]

Crumbs you can be a perma bear Whipmoney,

Have you some insight to share with the forum as to why CMS would not add cxbladder to their list of thousands of providers ?

The Cxbladder laboratory in the US has already achieved CMS approval (CLIA) and they have also taken a bold step in providing CLIA approval for the New Zealand laboratory. As I understand, it is very rare indeed for CMS to approval any lab outside of the US.

In addition, Cxbladder outperforms any pre-existing competitive providers they may have, it reduces bladder cancer work up costs by one third, and Pacific Edge guidance based on the natural ongoing progression of discussion with CMS to become a provider is really very positive.


Edit: per post below

[Casino]

Interesting article. We hear a lot on this forum about CMS coverage but has anyone considered the impact of PEB not receiving this? Surely this would send the share price into a tailspin as its their largest viable market..?

Do you think they would go back to the drawing board/lab? Or fold like Predictive Bioscience?

Everything about the CertNdx story from inception to pulling the plug is fishy. They were only told to produce a convincing study. Isn't it strange that they shut it down given how great their product was?

If the science is good, then the risk is small and delays limited. Authorities in the US have a lot of discretion and work closely with respected experts. I think of it as a great moat to hold off the next CertNdx. It is also good that the US healthcare reforms place much greater emphasis on disease prevention. There are a lot of hyperboles in regards to Obamacare but many of the changes I read about seem quite sensible.

[Casino]

Crumbs you can be a perma bear and a misery Whipmoney,

Have you some insight to share with the forum as to why CMS would not add cxbladder to their list of thousands of providers ?

The Cxbladder laboratory in the US has already achieved CMS approval and retains CLIA accreditation, CMS have also taken a bold step in approving the New Zealand laboratory. As I understand, it is very rare indeed for CMS to approval any lab outside of the US.

In addition, cxbladder outperforms any pre-existing competitive providers they may have, it reduces bladder cancer work up costs by one third, and Pacific Edge guidance based on the natural progression of discussion with CMS is really very positive.

Cxbladder is not covered by CMS but the management thinks that it will go through 'in early 2014'. Such an announcement is way way way more important than making the NZX50.